Food noise Mounjaro: the “noise” of intrusive thoughts about food is not a diagnosis, but it is an experience researchers are starting to measure. Among 550 adults taking semaglutide, the share who recognised these thoughts fell from 47–63% before treatment to 15–20% afterwards, based on their own recollection (Advances in Therapy, 2026). For tirzepatide, the data are shorter and more indirect.
What does food noise mean with Mounjaro, and is it a diagnosis?
Food noise is the everyday term for thoughts about food that keep coming back, that you did not choose and that take up room in your day: what to eat, when, how to resist. It is not a medical diagnosis. We have covered how tirzepatide changes your relationship with food; here the focus is what this noise feels like in daily life and the data that measure it.
A review in Nutrition & Diabetes (2025) proposes defining it as persistent thoughts about food that the person perceives as unwanted or distressing and that may cause social, mental or physical harm, and notes that no established clinical definition or measurement method existed at the time. A theoretical review in Appetite (2026) agrees: little is known about what food noise exactly is, what causes it, or how a medication might quieten it. Keep this in mind: it is a word for an experience, not a disease, and it differs from ordinary thoughts about food by its intensity and its intrusiveness.
What do studies say about food noise on semaglutide?
On semaglutide there are two kinds of data: a recent self-report survey that asks directly about food noise, and a subgroup of a randomised trial that measures cravings with a validated questionnaire. Both point the same way, but they answer different questions and carry different levels of evidence.
The INFORM survey, published in Advances in Therapy in 2026, recruited 550 US adults using injectable semaglutide for weight management through an opinion panel. They answered 22 questions, including the five-item Food Noise Questionnaire. Respondents were 86% women with a mean age of 53, and 81% had been on treatment for at least four months. Recalling the time before treatment, they put their median score at 13 out of a possible 20; after starting, it was 6. The proportion agreeing with statements that indicate food noise fell from 47–63% before semaglutide to 15–20% after, depending on the statement.
The STEP 5 trial, published in Obesity in 2023, is a different kind of evidence: randomised against placebo over 104 weeks, it gave a 19-item questionnaire (the Control of Eating Questionnaire) to a subgroup of 88 participants on semaglutide 2.4 mg and 86 on placebo. Mean weight loss was 14.8% versus 2.4%. Craving control and craving for savoury food were better on semaglutide than placebo at weeks 20, 52 and 104; craving for sweet food and positive mood were better at weeks 20 and 52. P values were not adjusted for multiple testing, and the questionnaire measures cravings, not “noise” in the strict sense.
And on tirzepatide: what is known about food noise with Mounjaro?
For tirzepatide, the molecule in Mounjaro (sold as Zepbound for weight management in the US), we did not find a randomised trial that measured food noise with a dedicated questionnaire. What exists are neighbouring measures from short trials: appetite, cravings, reactivity to food in the environment. They agree with patient accounts but cannot put a number on the noise itself.
In a phase 1 trial published in Nature Medicine in 2025, 114 adults with overweight or obesity and no diabetes were randomised to weekly tirzepatide, placebo or open-label liraglutide for six weeks. At week 3, energy intake at an ad libitum lunch was 524.6 kcal lower on tirzepatide than on placebo (95% confidence interval −648.1 to −401.0). Questionnaires showed lower overall appetite, cravings, tendency to overeat, perceived hunger and reactivity to food in the environment, with no effect on deliberate dietary restriction. The trial was funded by Eli Lilly.
A secondary analysis of another phase 1 trial, in Diabetes, Obesity and Metabolism in 2025, followed 48 participants (24 on tirzepatide, 24 on placebo) for 18 weeks using the Food Craving Inventory. The overall score and cravings for sweets, carbohydrates and starches, and fast-food fats dropped more on tirzepatide; cravings for high-fat foods and for fruit and vegetables did not. The authors note that these effects weakened over the course of treatment, that the sample was 84% female and that the study was not powered for these analyses. Funding: Eli Lilly.
Finally, a cross-sectional study in Physiology & Behavior in 2026 compared 79 adults with obesity in three separate groups: 27 before treatment, 25 after one month on a GLP-1 receptor agonist and 27 after six months. Food noise scores were lower at six months than before treatment (p = 0.026), as were cravings and energy intake. This concerns GLP-1 receptor agonists in general, not tirzepatide alone, and different people at each stage rather than the same people followed over time.
Why does the quiet feel like such a big change?
On Mounjaro, many patients describe less a loss of appetite than a mental space regained: the thoughts that filled the day go quiet, and the room they took up frees itself for something else. Qualitative research, summarised in the review published by Appetite in 2026, indicates that this effect is welcomed and lets people feel more in control of their eating. In INFORM, 83% of respondents said they were satisfied with treatment, and most agreed that their mental health, self-confidence and habits had improved.
To spot this change in yourself, a few observation prompts to note down before and during treatment:
- Mental time. How often a day do you think about the next meal when you are not hungry?
- The struggle. Faced with a tempting food, does the decision take constant willpower, or does it settle itself?
- Intrusion. Do these thoughts pull you away from work, conversation or sleep?
- Emotional toll. Do you feel guilty or worn out by how much you think about eating?
These are prompts for personal observation, not a validated test: they help you describe your experience to a doctor in precise words.
What does a quieter food noise not fix?
A quieter food noise on Mounjaro does not fix the emotions that used to drive eating, the habits you built, or your relationship with your weight: it calms the noise, not its possible causes. A cross-sectional study of 60 adults with stable weight after bariatric surgery links higher food noise to stronger weight self-stigma, which shows the noise is not only a matter of appetite biology (Obesity, 2026).
Several questions also remain unanswered in the studies cited here: what happens to food noise when treatment stops, how long the effect lasts, and why it varies so much between people. If food thoughts hide an emotional need, our article on food addiction and tirzepatide explores the brain and reward circuitry; on fullness, see how satiety works on tirzepatide.
When should you talk to a doctor about food noise, especially with eating disorders?
Talk to a doctor if food thoughts come with loss of control, severe restriction, fear of eating or a history of eating disorders, both before and during Mounjaro treatment, because that is when professional guidance matters most. A review in the International Journal of Eating Disorders in 2026 explains that the mechanisms that reduce appetite and food preoccupation may, in vulnerable people, reinforce restriction, avoidance of regular meals and relapse.
That paper is a narrative review laying out emerging risks and research gaps, not a systematic review: it does not quantify those risks. It recommends screening for eating disorders before and during treatment. For the details, read our article on eating disorders and GLP-1 medications. Never change your dose or treatment without medical advice.
How can you track your relationship with food day to day?
Writing down what you notice makes an appointment more precise, whether you are discussing food noise, nausea or weigh-ins. With the MounjaGO app you track your weigh-ins and injections and can turn them into a PDF report to show your doctor; it does not measure food noise, so keep your observations separately, with dates, to line them up with your injections and weight. Discover MounjaGO.
To place your starting point, you can check your BMI and weight-loss projection; if cost is part of the decision, compare Mounjaro prices and coverage.
What are the limits of this food noise data?
The data on food noise with Mounjaro are still thin and uneven: much of it comes from self-report surveys, trial subgroups and cross-sectional studies, several funded by the manufacturers of the drugs. The figures in this piece should be read with the following reservations in mind.
- INFORM relies on recall of the pre-treatment state, in a convenience sample that was 86% women and funded by Novo Nordisk: it does not prove semaglutide caused the drop.
- The tirzepatide data come from short phase 1 trials (6 and 18 weeks) funded by Eli Lilly, which measure cravings and appetite, not food noise.
- The Physiology & Behavior study compares different groups at one point in time; it does not follow the same people.
- None of these studies says what happens after treatment stops, or beyond two years.
- Food noise has no consensus clinical definition: questionnaires differ from one study to the next.
Frequently asked questions
Is food noise a medical condition?
No. It is a popular term for intrusive thoughts about food, not a medical diagnosis. A 2025 review even notes that no clinical definition or established measure existed at the time. Very distressing food thoughts are still worth raising with a doctor.
Does Mounjaro make food noise disappear?
The available data show lower cravings and appetite on tirzepatide and a self-reported drop in food noise on semaglutide, not a disappearance. Responses vary: even in INFORM, 15–20% of respondents still recognised these thoughts while on treatment.
How long does it take for food noise to ease on Mounjaro?
None of the studies cited gives a figure for food noise itself. In the Nature Medicine phase 1 trial, differences in appetite and energy intake were already measured at week 3 on tirzepatide. The real pace varies by person and by the dose your doctor prescribes.
Does food noise come back when you stop Mounjaro?
The studies we opened do not measure what happens after stopping, so we can neither confirm nor rule it out. If you are thinking about stopping, talk to your doctor first; they can plan the next steps with you.
When should fewer food thoughts be a warning sign?
If you are eating far too little, skipping meals out of fear of eating, or have a history of eating disorders, tell your doctor. A 2026 review stresses that in vulnerable people, a drop in food preoccupation can reinforce restriction.
Sources
- Arnaut T, Duncan S, Faurby M et al. “Retrospective Assessment of Food Noise Changes After Initiation of Injectable Semaglutide for Weight Management in the USA: The INFORM Survey”. Advances in Therapy, 2026. PMID 42217114, accessed .
- “Two-year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5”. Obesity, 2023. PMID 36655300, accessed .
- Martin CK, Carmichael OT, Carnell S et al. “Tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial”. Nature Medicine, 2025. PMID 40555748, accessed .
- Kennedy SF, Knights A, Ravussin E et al. “Impact of tirzepatide treatment on participant-reported food craving and food preference”. Diabetes, Obesity and Metabolism, 2025. PMID 40874370, accessed .
- Rutigliani G, Mattes RD. “The effects of glucagon-like peptide-1 receptor agonists on chemosensory function and ingestive behavior”. Physiology & Behavior, 2026. PMID 42641845, accessed .
- Dhurandhar EJ, Maki KC, Dhurandhar NV, Kyle TK. “Food noise: definition, measurement, and future research directions”. Nutrition & Diabetes, 2025. PMID 40628707, accessed .
- “Food noise: A theoretical review”. Appetite, 2026. PMID 42772688, accessed .
- “Weight Self-Stigma and Food Noise During Post-Metabolic Bariatric Surgery Weight Stability”. Obesity, 2026. PMID 42782188, accessed .
- Škudar S. “Eating Disorders in the GLP-1 Era: A Spotlight on Emerging Clinical Risks, Research Gaps, and Practice Priorities”. International Journal of Eating Disorders, 2026. PMID 42223191, accessed .
Medical disclaimer. This article is for information only and does not replace medical advice. The figures come from studies with very different methods and limits, and do not predict your individual experience. Food noise is not a diagnosis; if you have distressing food thoughts, loss of control or restriction, see a doctor. Any decision to start, change or stop a treatment should be made with a healthcare professional. Review current as of October 5, 2026.